Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19d9b4005d9c717b129b835e33e5f39f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-51 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2015-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ac7e7abaa5696b8567c71bffaf17743 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4696d4e7b1e462cce3524df82a0edc10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3de2353ea502de815aa7a746b61b39c8 |
publicationDate |
2017-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2017073413-A1 |
titleOfInvention |
Methods and compositions for treating siglec-8 associated diseases |
abstract |
The invention provides methods and compositions for the prevention and treatment of Siglec-8 associated diseases such as chronic rhino sinusitis with concomitant asthma and aspirin-exacerbated respiratory disease. In particular, the invention provides methods for the prevention and treatment of Siglec-8 associated diseases through administration of antibodies or agonists that bind to human Siglec-8 or compositions comprising said antibodies or agonists. The invention also provides articles of manufacture or kits comprising antibodies or agonists that bind to human Siglec-8 for the prevention and treatment of Siglec-8 associated diseases such as chronic rhinosinusitis with concomitant asthma and aspirin-exacerbated respiratory disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111246880-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10774145-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10604577-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11203638-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112041338-A |
priorityDate |
2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |